Antibacterial activity of dipeptide constructs of acetylsalicylic acid and nicotinic acid

Drug Delivery

Volumn 14, Issue 2, 2007, Pages 105-109

  Bartzatt, Ronald ^a,c   Cirillo, Suat L G ^b   Cirillo, Jeffrey D ^b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c Durham Science Center   (United States)

Author keywords

Ampicillin; Aspirin; Escherichia Coli; Nicotinic Acid

Indexed keywords

2 [2 [[2 (ACETYLOXY)BENZOYL]AMINO]PROPANOYL]AMINO]PROPANOIC ACID; 2 [[2 [(PYRIDIN 3 YLCARBONYL)AMINO]PROPANOYL]AMINO]PROPANOIC ACID; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID DERIVATIVE; AMPICILLIN; DEXTRO ALANINE DEXTRO ALANINE DIPEPTIDE; DIPEPTIDE DERIVATIVE; NICOTINIC ACID; NICOTINIC ACID DERIVATIVE; PENICILLIN G; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; AQUEOUS SOLUTION; ARTICLE; BACTERIAL GROWTH; BACTERIUM COLONY; BIOAVAILABILITY; CONTROLLED STUDY; DRUG MIXTURE; DRUG SOLUBILITY; ESCHERICHIA COLI; GROWTH INHIBITION; NONHUMAN; PRIORITY JOURNAL;

AMPICILLIN; ANTI-BACTERIAL AGENTS; ASPIRIN; CHEMISTRY, PHARMACEUTICAL; COLONY COUNT, MICROBIAL; DIPEPTIDES; ESCHERICHIA COLI; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; NIACIN; PENICILLIN RESISTANCE; PENICILLINS;

EID: 33847045535     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.1080/10717540600740128     Document Type: Article

References (20)

1. Adwan, K., Abu-Hasan, N., Adwan, G., Jarrar, N., Abu-Shanab, B., and Al-Masri, M. 2004. Molecular epidemiology of antibiotic-resistant Escherichia coli isolated from hospitalized patients with urinary tract infections in Northern Palestine. Pol. J. Microbiol. 53(1):23-26.
2. Al Sweih, N., Jamal, W., and Rotimi, V. 2005. Spectrum and antibiotic resistance of uropathogens isolated from hospital and community patients with urinary tract infections in two large hospitals inKuwait. Med. Princ. Pract. 14(6):401-407.
3. Blomberg, B., Olsen, B., Hinderaker, S., Langeland, N., Gasheka, P., Jureen, R., Kyale, G., and Midtvedt, T. 2005. Antimicrobial resistance in urinary bacterial isolates from pregnant women in rural Tanzania: Implications for public health. Scand. J. Infect. Dis. 37(4):262-268.
4. Davis, B., Dulbecco, R., Eisen, H., and Ginsberg, H. Microbiology. New York: J. B. Lippincott Company, 1990.
5. Deshpande, L. M., Fritsche, R., and Jones, R. 2004. Molecular epidemiology of selected multidrug-resistant bacteria: a global report from the SENTRY Antimicrobial Survellience Program. Diag. Microbiol. Infect. Dis. 49:231-236.
6. Edge, T., and Hill, S., 2005. Occurrence of antibiotic resistance in Escherichia coli from surface waters and fecal pollution sources near Hamilton, Ontario. Can. J. Microbiol. 51(6):501-505.
7. Estrada-Garcia, T., Cerna, J., Paheco-Gil, L., Velasquez, R., Ochoa, T., Torres, J., and DuPont H. 2005. Drug-resistant diarrheogenic Escherichia coli, Mexico. Emerg. Infect. Dis. 11(8):1306-1308.
8. Kumar, A., Herbert, P., and Schweizer, P. 2005. Bacterial resistance to antibiotics. Active efflux and reduced uptake. Adv. Drug Deli. Rev. 57:1486-1513.
9. Fouda, S. I. 2001. Antibacterial activity of some nonsteroidal anti-inflammatory drugs. J. Microbiol. 53:283-295.
10. Hockertz, S., and Heckenberger, R. 1996. Treatment of an acute bacterial infection with a combination of acetylsalicylic acid/ibuprofen and interon gamma. Arzneimittelforschung 46(10):1012-1015.
11. Hong, H., Chun, J., and Lee, Y. 2004. Detection of extended-spectrum beta lactamase producing, multidrug-resistant environmental isolate of Escherichia coli that bind to human bladder cells. Microb. Drug Resist. 10(2):184-189.
12. Katler, E., and Weissmann, G. 1977. Steroids, aspirin, and inflammation. Inflammation 2(4):295-307.
13. Lau, S., Peng, M., and Chang, F. 2004. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. J. Microbiol., Immunol. Infect. 37(3):185-191.
14. Lipinski, C. A., Lombardo, F., Dominy, B.W., and Feeney, P. J. 1997. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deli. Rev. 23:1-25.
15. Marangos, M., Nightingale, C., Quintiliano, R., and Nicolau, D. 1997. Influence of aspirin on the treatment of experimental Enterococcus faecalis and methicillin resistant Staphylococcus aureus endocarditis. J. Infect. Dis. Pharmacother. 2(3):47-53.
16. Nataro, J., and Kaper, J.B. 1998. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 11:142-201.
17. Nguyen, T., Van Le, P., Le, C., and Weintraub, A. 2005. Antibiotic resistance in diarrheagenic Escherichia coli and Shigella strains isolated from children in Hanoi, Vietnam. Antimicrob. Agents Chemother. 49(2)816-819.
18. Obsuka, S., Ohta, M., Masuda, K., Arakawa, Y., Kaneda, T., and Kato, N. 1994. Lidocaine hydrochloride and acetylsalicylate kill bacteria by disrupting the bacterial membrane potential in different ways. Microbiol. Immunol. 38(6):429-434.
19. Poole, K., Russell, A., and Lambert P. 2005. Mechanisms of antimicrobial resistance: opportunities for new targeted therapies. Adv. Drug Deli. Rev. 57:1443-1445.
20. Reinthaler, F., Posch, J., Feieri, G., Wust, G., Haas, D., Ruckenbauer, G., Mascher, F., and Marth, E. 2003. Antibiotic resistance of E. coli in sewage and sludge. Water Res. 37(8):1685-1690.